AMY LINDQUIST: Open Payments
NPI 1275733107 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,465 in 73 payments from 19 companies in 2025. Trend: 2023 $1,420 · 2024 $1,296 · 2025 $1,465
Food & beverage: $1,465
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 27 | $368 |
| ABIOMED | 1 | $129 |
| E.R. Squibb & Sons, L.L.C. | 5 | $109 |
| Novo Nordisk Inc | 6 | $106 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $96 |
| PFIZER INC. | 4 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $86 |
| AstraZeneca Pharmaceuticals LP | 3 | $79 |
| Boston Scientific Corporation | 3 | $68 |
| Medtronic, Inc. | 1 | $57 |
Products named: LEQVIO, Ozempic, JARDIANCE, VYNDAQEL, Kerendia, WATCHMAN FLX, CAMZYOS, WAINUA.
Industry payments across TN — which companies pay providers there.
